E. Goguet

发表

Durability of antibody responses and frequency of clinical and subclinical SARS-CoV-2 infection six months after BNT162b2 COVID-19 vaccination in healthcare workers

W. Wang, C. Broder, R. Vassell, 2021, medRxiv.

Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection

C. Broder, S. Pollett, T. Burgess, 2022, PloS one.

Post-vaccination Omicron infections induce broader immunity across antigenic space than prototype mRNA COVID-19 booster vaccination or primary infection

Rupal M Mody, C. Broder, B. Agan, 2022, bioRxiv.

Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers

C. Broder, K. Bishop-Lilly, R. Cer, 2022, Open forum infectious diseases.

CX3CL1 as potential immunotherapeutic tool for bone metastases in lung cancer: A preclinical study

N. Glaichenhaus, D. Ambrosetti, H. Schmid-Antomarchi, 2022, Advances in Cancer Biology - Metastasis.

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

Rupal M Mody, C. Broder, B. Agan, 2021, bioRxiv.

Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history

C. Broder, B. Agan, L. Katzelnick, 2022, Cell Host & Microbe.

Venom Atypical Extracellular Vesicles as Interspecies Vehicles of Virulence Factors Involved in Host Specificity: The Case of a Drosophila Parasitoid Wasp

J. Gatti, A. Volkoff, M. Ravallec, 2019, Front. Immunol..

PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus.

D. Klinman, Defne Bayik, M. Kaplan, 2019, Journal of autoimmunity.

Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers

C. Broder, J. Powers, A. Snow, 2021, Open forum infectious diseases.

Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers

C. Broder, J. Powers, A. Snow, 2021, medRxiv.

Bivalent COVID-19 vaccine antibody responses to Omicron variants suggest that responses to divergent variants would be improved with matched vaccine antigens

Wei Wang, R. Vassell, C. Weiss, 2023, medRxiv.

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies

C. Broder, B. Agan, L. Katzelnick, 2022, Science Translational Medicine.

Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers

C. Broder, R. Vassell, C. Weiss, 2022, Emerging infectious diseases.

TLR Agonist Therapy of Metastatic Breast Cancer in Mice

D. Klinman, D. Tross, E. Goguet, 2023, Journal of immunotherapy.

Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers

D. Scott, C. Broder, J. Powers, 2021, BMC Infectious Diseases.

Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durability

C. Broder, S. Anderson, S. Pollett, 2023, Frontiers in immunology.

Comparative Cohort Study of Post-Acute Covid-19 Infection with a Nested, Randomized Controlled Trial of Ivabradine for Those With Postural Orthostatic Tachycardia Syndrome (The COVIVA Study)

C. Dalgård, M. Haigney, M. Tanofsky-Kraff, 2023, medRxiv.